IDHIFA (enasidenib) recall in Canada: Market withdrawal
In plain language
This recall involves IDHIFA (enasidenib) 50 mg and 100 mg tablets sold in Canada. It's being recalled because a study did not show improved survival for patients. Do not start IDHIFA if you are a new patient. Patients currently using IDHIFA should speak to their healthcare professional.
What to do
- Do not start IDHIFA if you are a new patient.
- Speak to your healthcare professional if you are currently using IDHIFA.
- Your healthcare professional can apply for continued access through Health Canada's Special Access Program.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
IDHIFA (enasidenib)
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves IDHIFA (enasidenib) 50 mg and 100 mg tablets sold in Canada. It's being recalled because a study did not show improved survival for patients. Do not start IDHIFA if you are a new patient. Patients currently using IDHIFA should speak to their healthcare professional.
What should consumers do?
Do not start IDHIFA if you are a new patient. Speak to your healthcare professional if you are currently using IDHIFA. Your healthcare professional can apply for continued access through Health Canada's Special Access Program.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on June 8, 2023.
Is the IDHIFA brand affected by this recall?
Yes, IDHIFA products are affected by this recall. This recall involves IDHIFA (enasidenib) 50 mg and 100 mg tablets sold in Canada. It's being recalled because a study did not show improved survival for patients. Do not start IDHIFA if you are a new patient. Patients currently using IDHIFA should speak to their healthcare professional.